The donation will support the construction of a best-in-class ICU which will be named in honor of the foundation and co-founders Aleta and Rich Taylor and family.

State health officials said as a worst-case scenario the state could see 8,162 cases and 3,644 hospitalizations on May 18, with a similar peak in mid-June. A moderate scenario called for an April 18 peak of 5,405 positive cases and 2,669 people in the hospital, according to models. Cases would stay above 4,000 until mid-May, and hospitalizations would not fall below 2,000 until May 18.

The latest NJBIZ discussion focused on how businesses are going to have to think about how to keep their workforce safe in the months to come, and more.

The facility will significantly expand AtlantiCare’s resources for increasing access to care and addressing health care disparities, as well as expand Medical Education opportunities to proactively address the anticipated national shortage of physicians.

The Franklin Lakes-based company's BD Veritor Plus System can detect SARS-CoV-2, Influenza A, Influenza B from a single patient sample in 15 minutes.

The acquisition underscores the division's commitment to improving the health of women by addressing the unmet medical needs in maternal health through safer childbirth.

Former New Jersey CannaBusiness Association President Scott Rudder has been named chief strategy officer at the American Journal of Endocannabinoid Medicine, based out of Woodland Park. AJEM has also brought on Dr. Uma Dhanabalan, a well-known doctor in the cannabis space nationwide, as medical director. The newest issue of the journal includes peer-reviewed articles on ...

Eligibility expanded to food production, distribution and agriculture workers; any remaining eldercare staff; warehousing and logistics; clergy; judicial workers; postal and shipping workers; elections personnel; hospitality; medical supply chain, and social services support staff.

John Harlow is joining the Morristown-based pure-play antibiotics company effective immediately where he will build upon its existing platform and enhance its portfolio with additional products that address therapeutic areas of critical need.

"From the beginning of this pandemic, Johnson & Johnson has recognized that no one is safe until everyone is safe, and we have been committed to equitable, global access to new COVID-19 vaccines," said J&J CEO and Chairman Alex Gorsky. "Our support for the COVAX Facility, combined with supplementary agreements with countries and regions, will help accelerate global progress toward ending the COVID-19 pandemic."

The mixed-use facility will accommodate all U.S. administrative, clinical, commercialization, manufacturing, and research and development activities.

This is the company's first opening since completing the acquisition of South Jersey alternative treatment center Compassionate Care Foundation in July.